SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 4.97%338M | 633.33%272M | 93.04%-11M | 110.78%86M | -8.33%-26M | 547.22%322M | 80.31%-51M | 64.57%-158M | 16.35%-798M | 93.70%-24M |
Net income from continuing operations | 156.63%47M | 66.67%-51M | 57.32%-102M | 73.13%-466M | 102.04%8M | 75.44%-83M | 73.16%-153M | 44.93%-239M | 51.18%-1.73B | 64.49%-392M |
Operating gains losses | ---2M | -100.00%-2M | 400.00%3M | -233.33%-4M | 50.00%-2M | ---- | -200.00%-1M | -200.00%-1M | -40.00%3M | -500.00%-4M |
Depreciation and amortization | -2.70%36M | -5.56%34M | 14.29%40M | -3.33%145M | -7.50%37M | -2.63%37M | -2.70%36M | 2.94%35M | -56.52%150M | -55.06%40M |
Other non cash items | -131.43%-81M | -200.00%-15M | 366.67%8M | -267.80%-99M | -547.06%-76M | -1,850.00%-35M | 25.00%15M | -110.71%-3M | -97.09%59M | -97.19%17M |
Change In working capital | -11.37%265M | 677.14%202M | 23.47%-75M | 704.35%139M | -130.68%-27M | 260.24%299M | -9.38%-35M | 40.24%-98M | 84.03%-23M | 203.53%88M |
-Change in receivables | -204.00%-152M | -139.29%-67M | -373.68%-90M | -21.88%-195M | -125.00%-99M | -196.15%-50M | 47.17%-28M | 83.62%-19M | 11.60%-160M | 61.74%-44M |
-Change in inventory | -250.00%-7M | --0 | 0.00%1M | -116.67%-1M | 40.00%-3M | -150.00%-2M | 400.00%3M | -88.89%1M | 700.00%6M | ---5M |
-Change in payables and accrued expense | 630.43%168M | --16M | 8.11%-102M | -105.47%-7M | -40.88%81M | -8.00%23M | ---- | -94.74%-111M | -6.57%128M | 6.20%137M |
-Change in other working capital | -21.95%256M | 2,630.00%253M | 274.19%116M | 11,300.00%342M | ---6M | 16,300.00%328M | -1,100.00%-10M | --31M | 103.03%3M | --0 |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 4.97%338M | 633.33%272M | 93.04%-11M | 110.78%86M | -8.33%-26M | 547.22%322M | 80.31%-51M | 64.57%-158M | 16.35%-798M | 93.70%-24M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -86.11%65M | -33.33%48M | -129.78%-352M | 276.18%1.87B | -56.18%149M | 392.50%468M | 141.38%72M | 210.78%1.18B | 61.48%-1.06B | 121.42%340M |
Net PPE purchase and sale | -20.00%-12M | -83.33%-11M | ---7M | 6.52%-43M | -50.00%-27M | 9.09%-10M | 25.00%-6M | --0 | 4.17%-46M | 45.45%-18M |
Net intangibles purchase and sale | -62.50%-13M | 54.55%-5M | 50.00%-3M | -31.25%-21M | 162.50%5M | -700.00%-8M | -175.00%-11M | -100.00%-6M | -33.33%-16M | -14.29%-8M |
Net business purchase and sale | ---1M | ---5M | ---38M | --0 | --0 | --0 | --0 | --0 | -4,550.00%-372M | -1,257.14%-95M |
Net investment purchase and sale | -110.96%-47M | --0 | -129.97%-345M | 356.52%1.75B | -72.83%119M | 598.84%429M | 136.11%52M | 229.18%1.15B | 74.86%-683M | 126.69%438M |
Net other investing changes | --92M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -86.11%65M | -33.33%48M | -129.78%-352M | 276.18%1.87B | -56.18%149M | 392.50%468M | 141.38%72M | 210.78%1.18B | 61.48%-1.06B | 121.42%340M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -578.95%-129M | 154.24%32M | 5.13%-610M | 31.37%-770M | 94.10%-50M | 73.24%-19M | 49.57%-59M | -647.67%-643M | -117.09%-1.12B | -120.80%-848M |
Net issuance payments of debt | 40.91%-13M | 15.38%-22M | 18.27%-501M | 27.20%-688M | 96.63%-27M | 48.84%-22M | 69.41%-26M | -3,986.67%-613M | -153.09%-945M | -2,127.78%-802M |
Net common stock issuance | ---58M | ---34M | ---97M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | 0.00%7M | 0.00%9M | 0.00%4M | 100.00%16M | -157.14%-4M | 600.00%7M | --9M | --4M | -82.61%8M | 250.00%7M |
Net other financing activities | -569.23%-61M | 419.23%83M | 33.33%-2M | 28.00%-18M | 75.00%-3M | -31.58%13M | -1,400.00%-26M | 91.18%-3M | -100.57%-25M | -100.30%-12M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -578.95%-129M | 154.24%32M | 5.13%-610M | 31.37%-770M | 94.10%-50M | 73.24%-19M | 49.57%-59M | -647.67%-643M | -117.09%-1.12B | -120.80%-848M |
Net cash flow | ||||||||||
Beginning cash position | 7.23%2.45B | -10.12%2.11B | 60.76%3.14B | -60.89%1.95B | 23.33%3.02B | -18.30%2.28B | -30.59%2.35B | -60.89%1.95B | 129.68%4.99B | -9.44%2.45B |
Current changes in cash | -64.46%274M | 1,026.32%352M | -355.38%-973M | 139.81%1.19B | 113.72%73M | 354.46%771M | 93.09%-38M | 123.83%381M | -204.45%-2.98B | -125.23%-532M |
Effect of exchange rate changes | 568.57%164M | 41.94%-18M | -388.89%-52M | 98.25%-1M | 27.03%47M | 18.60%-35M | 29.55%-31M | 460.00%18M | -54.05%-57M | 236.36%37M |
End cash Position | -4.41%2.89B | 7.23%2.45B | -10.12%2.11B | 60.76%3.14B | 60.76%3.14B | 23.33%3.02B | -18.30%2.28B | -30.59%2.35B | -60.89%1.95B | -60.89%1.95B |
Free cash flow | 3.78%302M | 432.89%253M | 85.21%-25M | 99.31%-6M | 10.91%-49M | 438.37%291M | 72.16%-76M | 63.18%-169M | 16.07%-872M | 87.03%-55M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |